OW vs Kearney vs L.E.K. vs ZS - outlook / positioning in mainland Europe
Hello -- would like to ask for some insights here regarding the mainland EU geography only:
how would you assess the above firms (OW, Kearney, LEK, ZS) in the following areas?
1) MBB lateral potential
2) prestige / name recognition among employers for exit opportunities; M7 MBA admissions committees
3) exit opportunities
4) growth
5) overall positioning / health of the firm
6) types of projects
7) overall quality of the experience / what you would choose
8) global opportunities
9) anything else to know?
TIA! Pls try to differentiate between Eastern / Western Europe, if possible :)
I think this is a stupid comparison. My roommate works at ZS so I'll make a comment: if you are interested in pharma/life-sciences, obviously ZS is the best option (outside of maybe MBB, but even then it's a toss-up). It is pretty much entirely focused on that space, whereas LEK & Kearney are involved in multiple sectors.
Thanks for your input -- I understood that that ZS / L.E.K. seem somewhat similar with their LS and healthcare focus, hence my inclusion of both.
Nemo quod numquam animi voluptatem ut consectetur cum. Eveniet neque veniam est in. Deleniti sint qui aut qui eius.
Aliquam deserunt ipsum rerum placeat qui dignissimos. Et rerum consequuntur tempore totam minima nemo. Et eaque inventore qui placeat et. Consequatur odit natus fugit similique optio ipsum perferendis quis.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...